deltatrials
Completed OBSERVATIONAL NCT02763462

The Etiology of Acute Febrile Illness Requiring Hospitalization (AFIRE)

The Etiology of Acute Febrile Illness Requiring Hospitalization (AFIRE). A Multicenter Study of the Indonesia Research Partnership on Infectious Disease (INA-RESPOND)

Sponsor: Ina-Respond

Conditions Acute Febrile Illness
Updated 16 times since 2017 Last updated: May 1, 2023 Started: Jul 31, 2013 Primary completion: Oct 31, 2016 Completion: Aug 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute Febrile Illness and is currently completed. Ina-Respond leads this study, which shows 16 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Mar 2019 · 8 months · monthly snapshot~Mar 2019 – ~Sep 2019 · 6 months · monthly snapshot~Sep 2019 – ~Aug 2020 · 11 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Mar 2023 · 15 months · monthly snapshot~Mar 2023 – ~Jun 2023 · 3 months · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jun 2023 — Jul 2024 [monthly]

    Completed

  4. Mar 2023 — Jun 2023 [monthly]

    Completed

  5. Dec 2021 — Mar 2023 [monthly]

    Completed

▶ Show 11 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

  3. Aug 2020 — Nov 2020 [monthly]

    Completed

  4. Sep 2019 — Aug 2020 [monthly]

    Completed

  5. Mar 2019 — Sep 2019 [monthly]

    Completed

  6. Jul 2018 — Mar 2019 [monthly]

    Completed

  7. Jun 2018 — Jul 2018 [monthly]

    Completed

  8. May 2018 — Jun 2018 [monthly]

    Completed

  9. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  10. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  11. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ina-Respond
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Data source: Ina-Respond

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations